Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 25350
Event :SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference

Dates :Wednesday October 18th, 2017 - Thursday October 19th, 2017

Location :Holiday Inn Kensington Forum
97 Cromwell Road
SW7 4DN London, United Kingdom

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th and 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
 
Aimed at an audience of senior scientists and oncology specialists involved in targeting rare diseases therapies and drug research, Orphan Drugs UK 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of clinical trial process. The 7th annual conference will capture expert insight through dedicated focus new therapies for different rare diseases, the importance of orphan drug development and reimbursement and repurposing. 
 
Join us this October for strategic direction from the Rare Disease community and leverage your knowledge with the key requirements and tools for successful patient recruitment and retention through informed guidance delivered by a panel of industry experts.
 
Featured Speakers:
 
. Olivier Morand, Clinical Science Program Head, Actelion Pharmaceuticals
. Larissa Kerecuk, Rare Disease Lead, Consultant Paediatric Nephrologist, Birmingham Children’s Hospital
. Oliver Timmis, CEO, AKU Society
. Stuart Hughes, Director, Head of Pharmacology, Vertex
. Christine Lavery, Group Chief Executive, MPS Society
. Olaf Ritzeler, External Innovation Lead, Sanofi
. Stephen Marcus, CEO, Cantex Pharmaceuticals
 
Exclusive highlights in 2017:
 
. Learn about new therapies for different rare diseases, and how these can successfully be applied to other diseases with similar attributes
. Hear what opportunities and challenges come with working on rare diseases, as well as the development of the world’s first rare disease centre for children
. Expand your knowledge on patient collaboration and patient centric models with the stream on patient engagement
 
URLs:
 
Price:
Book by 31st May for a £400 Discount : GBP 1099, 
Book by 30th June for a £300 Discount : GBP 1199, 
Book by 31st August for a £200 Discount : GBP 1299, 
Standard Price: GBP 1499
 
Time: 8:00 am to 5:30 pm
 
Speakers: ADB Medical, Chiesi Farmaceutici S.p.A., Sanofi, Summit Therapeutics, Findacure, AKU Society, GlaxoSmithKline, Vertex Pharmaceuticals, MPS Society, Birmingham Children's Hospital, Deutsches Krebsforschungszentrum, Alexion Pharma GmbH, Cantex Pharmaceuticals, Actelion Pharmaceuticals, Action Duchenne, Selecta Biosciences, Cambridge Rare Disease Network (CRDN), Birmingham Children's Hospital

Location

Map and directions
Conference address :
Holiday Inn Kensington Forum
97 Cromwell Road
SW7 4DN London
United Kingdom
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference Medicine
orphan drugs, rare diseases, market access, venture capitals, pharma market access, orphan drugs pricing, orphan medicinal product
Professionals
-- -- --
English

Other

For more information on SMi's 7th annual Orphan Drugs and Rare Diseases UK Conference, plsase contactr SMi Group

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event